
Advancing Market Access with Real-World Data
European health systems and HTA bodies require clear clinical and economic evidence to enable adoption.
View this case study to learn how the PPD™ Vantage™ Real-World Data Analyzer combined NHS data with clinical evidence to deliver a UK-focused budget impact model—supporting NICE early value assessment and adoption across leading NHS organizations.
Learn more about our real-world data solutions.
